Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
ARWR
ARWR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ARWR News
CRISPR Therapeutics Shares Surge on Strong Earnings and Pipeline Growth
Feb 26 2026
Benzinga
Arrowhead Pharmaceuticals to Participate in Multiple Upcoming Conferences
Feb 24 2026
Newsfilter
Morgan Stanley Lowers Arrowhead Price Target to $78
Feb 18 2026
Yahoo Finance
Strategic Shift in Biotech Dealmaking
Feb 17 2026
Globenewswire
Strategic Shift in Biopharma Dealmaking
Feb 17 2026
Newsfilter
Casgevy Therapy Revenue Shows Significant Growth
Feb 13 2026
Benzinga
Arrowhead Pharmaceuticals Q1 2026 Earnings Call Highlights
Feb 06 2026
seekingalpha
Arrowhead Pharmaceuticals Q1 Earnings Exceed Expectations
Feb 05 2026
seekingalpha
Arrowhead Pharmaceuticals Set to Announce Q1 Earnings on February 5th
Feb 04 2026
seekingalpha
Privium Fund Management Reduces Arrowhead Holdings
Feb 03 2026
Fool
Privium Fund Management Sells Arrowhead Shares
Feb 03 2026
NASDAQ.COM
Longevity Infrastructure Market Undergoes Structural Reset
Jan 29 2026
PRnewswire
Global Capital Shifts to Longevity Infrastructure Valued at $27 Trillion
Jan 29 2026
Newsfilter
Arrowhead Pharmaceuticals to Host Q1 2026 Financial Results Call on February 5, 2026
Jan 20 2026
Newsfilter
Sanofi Secures Approval for Two Innovative Drugs Targeting Heart Disease and High Triglycerides
Jan 15 2026
NASDAQ.COM
Anticipate a Hectic Year for Obesity Medications with New Pills Launching
Jan 12 2026
Barron's
Show More News
